1231 related articles for article (PubMed ID: 11447155)
1. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godfroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Oct; 69(10):6264-70. PubMed ID: 11553569
[TBL] [Abstract][Full Text] [Related]
3. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
Al-Mariri A; Mahmoud NH; Hammoud R
Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
[TBL] [Abstract][Full Text] [Related]
4. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
Al-Mariri A
Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
6. Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.
Al-Mariri A; Tibor A; Lestrate P; Mertens P; De Bolle X; Letesson JJ
Infect Immun; 2002 Apr; 70(4):1915-23. PubMed ID: 11895955
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
8. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
[TBL] [Abstract][Full Text] [Related]
9. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
Oliveira SC; Harms JS; Banai M; Splitter GA
Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
González-Smith A; Vemulapalli R; Andrews E; Oñate A
Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
Tewary P; Sukumaran B; Saxena S; Madhubala R
Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055
[TBL] [Abstract][Full Text] [Related]
15. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
16. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
17. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW
Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
Tadepalli G; Konduru B; Murali HS; Batra HV
Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
[TBL] [Abstract][Full Text] [Related]
19. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
20. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
